COMMERCIALIZATION SOLUTIONS FOR THE ORTHOPEDIC INDUSTRY
APRIL 2020 | VOLUME 1

Our interview with Vinod Dasa, M.D. highlights how automating the hospital/device company supply chain will eliminate waste, reduce redundancies and improve inventory management.

Orthopedic device companies such as Stryker, Zimmer Biomet, Exactech, Smith+Nephew and Conformis are pulling back their financial outlooks as they brace for revenue declines.

From inventory management programs to regulatory and clinical trial support help and production of personal protective gear, orthopedic companies are rising to the challenges before us.

FDA’s Center for Devices and Radiological Health published a second letter to companies participating in the submission process and created a hub for COVID-19 final guidance .

To ease the strain on patients whose orthopedic procedures have been canceled, surgeon, device company and service provider leaders are seeking to accelerate FDA clearance for critical innovations.

Dimension Inx is bringing 3D-painted orthopedic devices to market to aid tissue repair and bone regeneration. The materials offer alternatives to titanium and polymers.

How can you handle medical device risk management and the change from ALARP to AFAP? Staying current with regulations, standards and guidance is key.

The device is specifically designed to negate common risks of radial implants, such as limited range of motion, subluxation, distal component failure and osteolysis.
Did you miss it?

The joint replacement market—dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith+Nephew—surpassed $19 billion in 2019.

Copyright © 2020. All Rights Reserved.